Skip to Content

Filter by:


Future innovations in health care and prevention require research across a full spectrum of biomedical science, from basic and translational research to implementation science and comparative effectiveness research. 

AAMC advocates for funding and appropriate regulation by major federal agencies and organizations supporting this research, including the National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), and the Department of Veterans Affairs (VA).

Ensuring a sustainable research mission is essential to achieve long-term health priorities, develop new therapeutics and preventive measures, focus on patient-centered outcomes, and reduce health disparities. 

We also work to ensure the integrity of biomedical research, especially research involving human subjects, including privacy protections and management of financial conflicts of interest.


Responsible Conduct of Research
Research with AnimalsStem Cell Research and Regenerative Medicine

News and Updates

President Trump Announces Deal to Temporarily Fund the Federal Government

January 25, 2019

President Trump Jan. 25 announced that a deal has been reached with congressional leaders to fund the government through Feb. 15.

AAMC Submits Comments to NIH on Provisions for a Data Management and Sharing Policy

December 14, 2018

The AAMC Dec. 10 submitted comments to the National Institutes of Health (NIH) in response to a request for information (RFI) on proposed provisions to serve as a foundation for a data management and sharing policy for NIH-funded research.

NIH Advisory Committee to the Director Next Generation Working Group Presents Final Recommendations

December 14, 2018

The National Institutes of Health (NIH) Advisory Committee to the Director (ACD) Dec. 13-14 held a public meeting covering a range of topics, including the next generation of researchers initiative, foreign influences on research integrity, and sexual harassment.

NIST Releases Review of Federal Tech Transfer Policies Under the Return on Investment Initiative

December 14, 2018

The Department of Commerce's (DoC) National Institute of Standards and Technology (NIST) Dec. 6 issued a draft green paper titled Return on Investment Initiative for Unleashing American Innovation. The green paper presents preliminary proposals on university tech transfer from federally funded research, as well as commercialization efforts from agency intramural research programs.

House OGR Subcommittees Hold Hearing on Alternatives to Fetal Tissue Research

December 14, 2018

The House Oversight and Government Reform (OGR) Committee Subcommittees on Healthcare, Benefits, and Administrative Rules and Government Reform Dec. 13 held a hearing titled “Exploring Alternatives to Fetal Tissue Research.” Witnesses included Sally Temple, PhD, Scientific Director at the Neural Stem Cell Institute; Tara Sander Lee, PhD, Associate Scholar at the Charlotte Lozier Institute; and David A. Prentice, PhD, Vice President and Research Director of the Charlotte Lozier Institute.

On Government Affairs

Research Spectrum

Testimony and Correspondence